Literature DB >> 22427690

Various p53 mutant proteins differently regulate the Ras circuit to induce a cancer-related gene signature.

Hilla Solomon1, Yosef Buganim, Ira Kogan-Sakin, Leslie Pomeraniec, Yael Assia, Shalom Madar, Ido Goldstein, Ran Brosh, Eyal Kalo, Tsevi Beatus, Naomi Goldfinger, Varda Rotter.   

Abstract

Concomitant expression of mutant p53 and oncogenic Ras, leading to cellular transformation, is well documented. However, the mechanisms by which the various mutant p53 categories cooperate with Ras remain largely obscure. From this study we suggest that different mutant p53 categories cooperate with H-Ras in different ways to induce a unique expression pattern of a cancer-related gene signature (CGS). The DNA-contact p53 mutants (p53(R248Q) and p53(R273H)) exhibited the highest level of CGS expression by cooperating with NFκB. Furthermore, the Zn(+2) region conformational p53 mutants (p53(R175H) and p53(H179R)) induced the CGS by elevating H-Ras activity. This elevation in H-Ras activity stemmed from a perturbed function of the p53 transcription target gene, BTG2. By contrast, the L3 loop region conformational mutant (p53(G245S)) did not affect CGS expression. Our findings were further corroborated in human tumor-derived cell lines expressing Ras and the aforementioned mutated p53 proteins. These data might assist in future tailor-made therapy targeting the mutant p53-Ras axis in cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22427690     DOI: 10.1242/jcs.099663

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  34 in total

1.  Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of AMPK activation.

Authors:  Ge Zhou; Jiping Wang; Mei Zhao; Tong-Xin Xie; Noriaki Tanaka; Daisuke Sano; Ameeta A Patel; Alexandra M Ward; Vlad C Sandulache; Samar A Jasser; Heath D Skinner; Alison Lea Fitzgerald; Abdullah A Osman; Yongkun Wei; Xuefeng Xia; Zhou Songyang; Gordon B Mills; Mien-Chie Hung; Carlos Caulin; Jiyong Liang; Jeffrey N Myers
Journal:  Mol Cell       Date:  2014-05-22       Impact factor: 17.970

2.  Mutant p53 expression in fallopian tube epithelium drives cell migration.

Authors:  Suzanne M Quartuccio; Subbulakshmi Karthikeyan; Sharon L Eddie; Daniel D Lantvit; Eoghainín Ó hAinmhire; Dimple A Modi; Jian-Jun Wei; Joanna E Burdette
Journal:  Int J Cancer       Date:  2015-04-11       Impact factor: 7.396

3.  Limitations of the 'ambush hypothesis' at the single-gene scale: what codon biases are to blame?

Authors:  Robert L Bertrand; Mona Abdel-Hameed; John L Sorensen
Journal:  Mol Genet Genomics       Date:  2014-10-12       Impact factor: 3.291

4.  BRAF kinase domain mutations are present in a subset of chronic myelomonocytic leukemia with wild-type RAS.

Authors:  Liping Zhang; Rajesh R Singh; Keyur P Patel; Francesco Stingo; Mark Routbort; M James You; Roberto N Miranda; Guillermo Garcia-Manero; Hagop M Kantarjian; L Jeffrey Medeiros; Rajyalakshmi Luthra; Joseph D Khoury
Journal:  Am J Hematol       Date:  2014-02-10       Impact factor: 10.047

5.  HOP expression is regulated by p53 and RAS and characteristic of a cancer gene signature.

Authors:  Stacey A Mattison; Gregory L Blatch; Adrienne L Edkins
Journal:  Cell Stress Chaperones       Date:  2016-12-16       Impact factor: 3.667

Review 6.  Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation.

Authors:  Yoav Shetzer; Alina Molchadsky; Varda Rotter
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

7.  Inhibition of breast cancer invasion by TIS21/BTG2/Pc3-Akt1-Sp1-Nox4 pathway targeting actin nucleators, mDia genes.

Authors:  J-A Choi; Y S Jung; J Y Kim; H M Kim; I K Lim
Journal:  Oncogene       Date:  2015-03-23       Impact factor: 9.867

8.  Cross-generational effects of alcohol dependence in humans on HRAS and TP53 methylation in offspring.

Authors:  Shirley Y Hill; Gregory Rompala; Gregg E Homanics; Nicholas Zezza
Journal:  Epigenomics       Date:  2017-08-11       Impact factor: 4.778

Review 9.  p53 mutations in cancer.

Authors:  Patricia A J Muller; Karen H Vousden
Journal:  Nat Cell Biol       Date:  2013-01       Impact factor: 28.824

10.  A protumorigenic secretory pathway activated by p53 deficiency in lung adenocarcinoma.

Authors:  Xiaochao Tan; Lei Shi; Priyam Banerjee; Xin Liu; Hou-Fu Guo; Jiang Yu; Neus Bota-Rabassedas; B Leticia Rodriguez; Don L Gibbons; William K Russell; Chad J Creighton; Jonathan M Kurie
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.